Literature DB >> 23639349

Chronic obstructive pulmonary disease in Portugal: Pneumobil (1995) and 2002 prevalence studies revisited.

J Cardoso1, J R Ferreira, J Almeida, J M Santos, F Rodrigues, M J Matos, M Gaspar.   

Abstract

BACKGROUND: Chronic Obstructive Pulmonary Disease (COPD) has been a leading cause of morbidity and mortality worldwide, over the years. In 1995, the implementation of a respiratory function survey seemed to be an adequate way to draw attention to neglected respiratory symptoms and increase the awareness of spirometry surveys. By 2002 there were new consensual guidelines in place and the awareness that prevalence of COPD depended on the criteria used for airway obstruction definition. The purpose of this study is to revisit the two studies and to turn public some of the data and respective methodologies.
METHODS: From Pneumobil study database of 12,684 subjects, only the individuals with 40+ years old (n = 9.061) were selected. The 2002 study included a randomized representative sample of 1,384 individuals with 35-69 years old.
RESULTS: The prevalence of COPD was 8.96% in Pneumobil and 5.34% in the 2002 study. In both studies, presence of COPD was greater in males and there was a positive association between presence of COPD and older age groups. Smokers and ex-smokers showed a higher proportion of cases of COPD.
CONCLUSIONS: Prevalence in Portugal is lower than in other European countries. This may be related to lower smokers' prevalence. Globally, the most important risk factors associated with COPD were age over 60 years, male gender and smoking exposure. All aspects and limitations regarding different recruitment methodologies and different criteria for defining COPD cases highlight the need of a standardized method to evaluate COPD prevalence and associated risks factors, whose results can be compared across countries, as it is the case of BOLD project.
Copyright © 2012 Sociedade Portuguesa de Pneumologia. Published by Elsevier España. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23639349     DOI: 10.1016/j.rppneu.2012.11.005

Source DB:  PubMed          Journal:  Rev Port Pneumol        ISSN: 0873-2159


  5 in total

1.  The respiratory research agenda in primary care in Portugal: a Delphi study.

Authors:  Vera Araújo; Pedro M Teixeira; John Yaphe; Jaime Correia de Sousa
Journal:  BMC Fam Pract       Date:  2016-08-31       Impact factor: 2.497

2.  Geographical distribution of COPD prevalence in Europe, estimated by an inverse distance weighting interpolation technique.

Authors:  Ignacio Blanco; Isidro Diego; Patricia Bueno; Eloy Fernández; Francisco Casas-Maldonado; Cristina Esquinas; Joan B Soriano; Marc Miravitlles
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-12-21

Review 3.  Inhaled Drug Therapy-Associated Adverse Reactions in Obstructive Respiratory Diseases: A Review of a Decade of Reporting to the Portuguese Pharmacovigilance System.

Authors:  Willy Fonseca; Cristina Monteiro; Luís Taborda-Barata
Journal:  Int J Environ Res Public Health       Date:  2021-11-25       Impact factor: 3.390

Review 4.  Global and regional estimates of COPD prevalence: Systematic review and meta-analysis.

Authors:  Davies Adeloye; Stephen Chua; Chinwei Lee; Catriona Basquill; Angeliki Papana; Evropi Theodoratou; Harish Nair; Danijela Gasevic; Devi Sridhar; Harry Campbell; Kit Yee Chan; Aziz Sheikh; Igor Rudan
Journal:  J Glob Health       Date:  2015-12       Impact factor: 7.664

5.  The cost-saving switch from inhaled corticosteroid-containing treatments to dual bronchodilation: a two-country projection of epidemiological and economic burden in chronic obstructive pulmonary disease.

Authors:  Kyriakos Souliotis; Luís Silva Miguel; Georgios Hillas; Margarida Borges; Giannis Papageorgiou; Diogo Viana; Joao Malhadeiro; Stéphane Soulard
Journal:  Ther Adv Respir Dis       Date:  2020 Jan-Dec       Impact factor: 4.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.